Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Myeloma Bispecific Antibody Research

Nizar Bahlis

MD

🏢University of Calgary🌐Canada

Professor of Medicine, Division of Hematology

45
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

Nizar Bahlis is a leading Canadian myeloma researcher who has been central to clinical trials of BCMA-targeting bispecific antibodies. His work with teclistamab has helped define dosing schedules and patient selection criteria for bispecific therapy. He leads multicenter Canadian studies evaluating novel immunotherapy combinations in myeloma.

Share:

🧪Research Fields 研究领域

Teclistamab
BCMAxCD3 bispecific
Myeloma clinical trials
Immune-based therapy
Canadian myeloma research

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-04-01 | All information from publicly available academic sources

关注 Nizar Bahlis 的研究动态

Follow Nizar Bahlis's research updates

留下邮箱,当我们发布与 Nizar Bahlis(University of Calgary)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment